REGN34:BVMF
Regeneron Pharmaceuticals
62,27 BRL
0,00%
(0,00) 1 d
9 oct, 16:56:00 GMT-3 · BRL
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de REGN34...
Abrir
60,78 BRL
Alto
62,27 BRL
Bajo
60,78 BRL
Cap. burs.
78,54 mil M
Vol. medio
910,00
Volumen
32,00
Máximo en 52 sem.
73,13 BRL
Mínimo en 52 sem.
49,47 BRL
Acciones en circulación
101,14 M
N.º de empleados
15 mil
Abrir
60,78 BRL
Alto
62,27 BRL
Bajo
60,78 BRL
Cap. burs.
78,54 mil M
Vol. medio
910,00
Volumen
32,00
Máximo en 52 sem.
73,13 BRL
Mínimo en 52 sem.
49,47 BRL
Acciones en circulación
101,14 M
N.º de empleados
15 mil
Noticias
De fuentes web y partners de noticias
ad-hoc-news.de
·
hace 39 minutos
Regeneron reports 84-week Pasatru results: stock pre-market at EUR 684.95
Yahoo Finance
·
hace 13 horas
Regeneron’s Rare Disease Drug Shows Zero New Abnormal Bone Growth In Extended Trial – REGN Stock Heads For Best Day In Over A Month
Investing.com UK
·
hace 15 horas
Regeneron reports sustained efficacy for FOP treatment Pasatru By Investing.com
ad-hoc-news.de
·
hace 17 horas
Regeneron stock stands at EUR 678.75 with P/ E of 18.8
Perfil
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
Acerca de Regeneron Pharmaceuticals
CEOLeonard Schleifer
Empleados15,3 mil
Fundación1988
SedeTarrytown, Nueva York, Estados Unidos
Sector-
Sitio webregeneron.com